Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ross J. Baldessarini, D.Sc., M.D.

Co-Author

This page shows the publications co-authored by Ross Baldessarini and Mauricio Tohen.
Connection Strength

7.989
  1. Tohen M, Khalsa HM, Salvatore P, Zarate CA, Strakowski SM, Sanchez-Toledo JP, Baldessarini RJ. The McLean-Harvard First-Episode Project: Early Course in 114 Cases of First-Episode Nonaffective Psychoses. J Clin Psychiatry. 2016 06; 77(6):781-8.
    View in: PubMed
    Score: 0.733
  2. Baldessarini RJ, Tondo L, Vazquez GH, Undurraga J, Bolzani L, Yildiz A, Khalsa HM, Lai M, Lepri B, Lolich M, Maffei PM, Salvatore P, Faedda GL, Vieta E, Tohen M. Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry. 2012 Feb; 11(1):40-6.
    View in: PubMed
    Score: 0.543
  3. Tohen M, Khalsa HK, Salvatore P, Vieta E, Ravichandran C, Baldessarini RJ. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord. 2012 Jan; 136(1-2):1-8.
    View in: PubMed
    Score: 0.530
  4. Baldessarini RJ, Salvatore P, Khalsa HK, Imaz-Etxeberria H, Gonzalez-Pinto A, Tohen M. Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J Affect Disord. 2012 Jan; 136(1-2):149-154.
    View in: PubMed
    Score: 0.530
  5. Baldessarini RJ, Salvatore P, Khalsa HM, Gebre-Medhin P, Imaz H, González-Pinto A, Perez J, Cruz N, Maggini C, Tohen M. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord. 2010 May; 12(3):264-70.
    View in: PubMed
    Score: 0.481
  6. Baldessarini RJ, Salvatore P, Khalsa HM, Tohen M. Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder. J Affect Disord. 2010 Oct; 126(1-2):299-302.
    View in: PubMed
    Score: 0.480
  7. Baldessarini RJ, Tondo L, Strombom IM, Dominguez S, Fawcett J, Licinio J, Oquendo MA, Tollefson GD, Valuck RJ, Tohen M. Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry. 2007 Jul-Aug; 15(4):133-45.
    View in: PubMed
    Score: 0.395
  8. Tohen M, Zarate CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003 Dec; 160(12):2099-107.
    View in: PubMed
    Score: 0.308
  9. Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE, McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate CA, Baker RW, Tohen M. Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol. 2003 Aug; 23(4):370-6.
    View in: PubMed
    Score: 0.301
  10. Salvatore P, Khalsa HK, Tohen M, Baldessarini RJ. Long-term morbidity in major affective and schizoaffective disorders following hospitalization in first psychotic episodes. Acta Psychiatr Scand. 2020 Oct 12.
    View in: PubMed
    Score: 0.248
  11. Tohen M, Strakowski SM, Zarate C, Hennen J, Stoll AL, Suppes T, Faedda GL, Cohen BM, Gebre-Medhin P, Baldessarini RJ. The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry. 2000 Sep 15; 48(6):467-76.
    View in: PubMed
    Score: 0.247
  12. Tondo L, Vázquez GH, Baethge C, Baronessa C, Bolzani L, Koukopoulos A, Mazzarini L, Murru A, Pacchiarotti I, Pinna M, Salvatore P, Sani G, Selle V, Spalletta G, Girardi P, Tohen M, Vieta E, Baldessarini RJ. Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study. Acta Psychiatr Scand. 2016 Jan; 133(1):34-43.
    View in: PubMed
    Score: 0.171
  13. Salvatore P, Bhuvaneswar C, Tohen M, Khalsa HM, Maggini C, Baldessarini RJ. Capgras' syndrome in first-episode psychotic disorders. Psychopathology. 2014; 47(4):261-9.
    View in: PubMed
    Score: 0.156
  14. Salvatore P, Baldessarini RJ, Khalsa HM, Indic P, Maggini C, Tohen M. Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal Risk. J Depress Anxiety. 2013 Jul 27; 2.
    View in: PubMed
    Score: 0.150
  15. Salvatore P, Baldessarini RJ, Khalsa HM, Vázquez G, Perez J, Faedda GL, Amore M, Maggini C, Tohen M. Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients. Acta Psychiatr Scand. 2014 Apr; 129(4):275-85.
    View in: PubMed
    Score: 0.150
  16. Salvatore P, Baldessarini RJ, Khalsa HM, Amore M, Di Vittorio C, Ferraro G, Maggini C, Tohen M. Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features. J Clin Psychiatry. 2013 Jul; 74(7):723-31; quiz 731.
    View in: PubMed
    Score: 0.150
  17. Baldessarini RJ, Undurraga J, Vázquez GH, Tondo L, Salvatore P, Ha K, Khalsa HM, Lepri B, Ha TH, Chang JS, Tohen M, Vieta E. Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand. 2012 Apr; 125(4):293-302.
    View in: PubMed
    Score: 0.135
  18. Yildiz A, Vieta E, Tohen M, Baldessarini RJ. Factors modifying drug and placebo responses in randomized trials for bipolar mania. Int J Neuropsychopharmacol. 2011 Aug; 14(7):863-75.
    View in: PubMed
    Score: 0.127
  19. Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL. Bipolar depression: overview and commentary. Harv Rev Psychiatry. 2010 May-Jun; 18(3):143-57.
    View in: PubMed
    Score: 0.120
  20. Baldessarini RJ, Bolzani L, Cruz N, Jones PB, Lai M, Lepri B, Perez J, Salvatore P, Tohen M, Tondo L, Vieta E. Onset-age of bipolar disorders at six international sites. J Affect Disord. 2010 Feb; 121(1-2):143-6.
    View in: PubMed
    Score: 0.113
  21. Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord. 2009 Dec; 119(1-3):22-7.
    View in: PubMed
    Score: 0.111
  22. Baethge C, Hennen J, Khalsa HM, Salvatore P, Tohen M, Baldessarini RJ. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord. 2008 Sep; 10(6):738-41.
    View in: PubMed
    Score: 0.107
  23. Baldessarini RJ, Tohen M. Is there a long-term protective effect of mood-altering agents in unipolar depressive disorder? Psychopharmacol Ser. 1988; 5:130-9.
    View in: PubMed
    Score: 0.102
  24. Khalsa HM, Salvatore P, Hennen J, Baethge C, Tohen M, Baldessarini RJ. Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord. 2008 Feb; 106(1-2):179-84.
    View in: PubMed
    Score: 0.099
  25. Salvatore P, Tohen M, Khalsa HM, Baethge C, Tondo L, Baldessarini RJ. Longitudinal research on bipolar disorders. Epidemiol Psichiatr Soc. 2007 Apr-Jun; 16(2):109-17.
    View in: PubMed
    Score: 0.097
  26. Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. J Clin Psychiatry. 2006 Aug; 67(8):1246-52.
    View in: PubMed
    Score: 0.093
  27. Salvatore P, Khalsa HM, Hennen J, Tohen M, Yurgelun-Todd D, Casolari F, Depanfilis C, Maggini C, Baldessarini RJ. Psychopathology factors in first-episode affective and non-affective psychotic disorders. J Psychiatr Res. 2007 Nov; 41(9):724-36.
    View in: PubMed
    Score: 0.092
  28. Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry. 2005 May; 162(5):1008-10.
    View in: PubMed
    Score: 0.085
  29. Chengappa KN, Hennen J, Baldessarini RJ, Kupfer DJ, Yatham LN, Gershon S, Baker RW, Tohen M. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord. 2005 Feb; 7(1):68-76.
    View in: PubMed
    Score: 0.084
  30. Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ. Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry. 2004 Dec; 65(12):1679-87.
    View in: PubMed
    Score: 0.083
  31. Vieta E, Calabrese JR, Hennen J, Colom F, Martínez-Arán A, Sánchez-Moreno J, Yatham LN, Tohen M, Baldessarini RJ. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry. 2004 Oct; 65(10):1420-8.
    View in: PubMed
    Score: 0.082
  32. Baldessarini RJ, Tohen M, Tondo L. Maintenance treatment in bipolar disorder. Arch Gen Psychiatry. 2000 May; 57(5):490-2.
    View in: PubMed
    Score: 0.060
  33. Tohen M, Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000 Feb; 157(2):220-8.
    View in: PubMed
    Score: 0.059
  34. Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, Conus P, DelBello MP, Duffy AC, Hillegers MHJ, Pfennig A, Post RM, Preisig M, Ratheesh A, Salvatore P, Tohen M, Vázquez GH, Vieta E, Yatham LN, Youngstrom EA, Van Meter A, Correll CU. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar Disord. 2019 12; 21(8):720-740.
    View in: PubMed
    Score: 0.058
  35. Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini RJ, Severus E. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord. 2019 08; 21(5):394-409.
    View in: PubMed
    Score: 0.057
  36. Khalsa HK, Baldessarini RJ, Tohen M, Salvatore P. Aggression among 216 patients with a first-psychotic episode of bipolar I disorder. Int J Bipolar Disord. 2018 Aug 11; 6(1):18.
    View in: PubMed
    Score: 0.053
  37. Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, Tohen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry. 1998 Aug; 59(8):405-14.
    View in: PubMed
    Score: 0.053
  38. Zarate CA, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M. Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry. 1997 Jul; 58(7):311-7.
    View in: PubMed
    Score: 0.049
  39. Gardner DM, Baldessarini RJ, Benzo J, Zarate CA, Tohen M. Switching between clozapine and risperidone treatment. Can J Psychiatry. 1997 May; 42(4):430-1.
    View in: PubMed
    Score: 0.049
  40. Zarate CA, Tohen M, Baraibar G, Zarate SB, Baldessarini RJ. Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993. J Affect Disord. 1997 Mar; 43(1):79-84.
    View in: PubMed
    Score: 0.048
  41. Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry. 1997 Jan; 54(1):49-55.
    View in: PubMed
    Score: 0.048
  42. Zarate CA, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry. 1995 Sep; 56(9):411-7.
    View in: PubMed
    Score: 0.043
  43. Tohen M, Castillo J, Baldessarini RJ, Zarate C, Kando JC. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry. 1995 Mar; 152(3):413-8.
    View in: PubMed
    Score: 0.042
  44. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62.
    View in: PubMed
    Score: 0.038
  45. Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv Rev Psychiatry. 1993 Sep-Oct; 1(3):131-44.
    View in: PubMed
    Score: 0.038
  46. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry. 1993 Jun; 50(6):448-55.
    View in: PubMed
    Score: 0.037
  47. Stoll AL, Tohen M, Baldessarini RJ. Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry. 1992 May; 149(5):638-40.
    View in: PubMed
    Score: 0.035
  48. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991 Dec; 48(12):1082-8.
    View in: PubMed
    Score: 0.034
  49. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA, Vieta E, Maggini C. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2011 Feb; 72(2):183-93.
    View in: PubMed
    Score: 0.030
  50. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA, Vieta E, Maggini C. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2009 Apr; 70(4):458-66.
    View in: PubMed
    Score: 0.027
  51. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994 Oct; 151(10):1409-16.
    View in: PubMed
    Score: 0.010
  52. Stoll AL, Tohen M, Baldessarini RJ, Goodwin DC, Stein S, Katz S, Geenens D, Swinson RP, Goethe JW, McGlashan T. Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry. 1993 Nov; 150(11):1668-73.
    View in: PubMed
    Score: 0.010
  53. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C. Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry. 1991 Sep; 148(9):1237-9.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.